Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
ACOR |
|
Phase 3 Results |
Neurology |
None |
|
Q4 2016
|
ACHN |
|
Phase 2 Results |
Other |
None |
|
Q4 2016
|
ACAD |
|
Phase 2 Results |
Neurology |
None |
|
12/28/2016
|
AAAP |
|
PDUFA |
Oncology |
Fast Track, Orphan Drug, Priority Review |
|
05/11/2016
|
AAAP |
|
Phase 3 Results |
Oncology |
Orphan Drug, Priority Review |
|
Q4 2016
|
EIGR |
|
Phase 2 Results |
Other |
None |
|
Q4 2016
|
EIGR |
|
Phase 2 Results |
Infectious Disease |
Fast Track |
|
Q4 2016
|
INNL |
|
NDA Submission |
Other |
None |
|
12/28/2016
|
CEMP |
|
PDUFA |
Other |
Fast Track |
|
11/17/2016
|
APRI |
|
NDA Submission |
Other |
None |
|